Literature DB >> 2166946

Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor.

R A Heller1, K Song, M A Onasch, W H Fischer, D Chang, G M Ringold.   

Abstract

Tumor necrosis factor (TNF) receptor (TNFR) was isolated as a 68-kDa glycoprotein from UC/HeLa 2-5 cells developed from a parental B-cell line (UC cells) to overexpress the receptor. Tryptic digests of two separate TNFR preparations provided amino acid sequences of four different peptides. Amino-terminal analysis indicated the presence of the amino-acid sequence Val-Ala-Phe-Thr-Pro, reported to be the amino-terminal sequence of a 30-kDa urinary TNF-binding protein II. Examination of the cultured medium of UC/HeLa 2-5 cells showed an abundance of a 40-kDa TNF-binding protein, indicating that the previously cited 30-kDa TNF-binding protein II is likely to be a shed form of the TNFR. Based on the peptide sequences, oligonucleotides were synthesized, and two of these were used as primers in the polymerase chain reaction to amplify cDNA sequences from poly(A)+ RNA of UC/HeLa 2-5 cells. These PCR fragments were radiolabeled and used to screen a cDNA library made from UC/HeLa 2-5 mRNA. Further analysis identified cDNA sequences that encoded the amino acid sequences of all four TNFR peptides. RNA blot-hybridization analysis of UC/HeLa 2-5 mRNA revealed a 3.8-kilobase transcript of the same size as the mRNA in the parental UC cells. Genomic Southern blots indicated the presence of a single gene in parental cells and a second, amplified gene in TNFR-overexpressing cells, suggesting amplification of the transfected gene as a possible mechanism for the increase in TNFR numbers in UC/HeLa 2-5 cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166946      PMCID: PMC54490          DOI: 10.1073/pnas.87.16.6151

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily.

Authors:  R G Goodwin; D Friend; S F Ziegler; R Jerzy; B A Falk; S Gimpel; D Cosman; S K Dower; C J March; A E Namen
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

2.  Selective inhibition of synthesis of enzymes for de novo fatty acid biosynthesis by an endotoxin-induced mediator from exudate cells.

Authors:  P H Pekala; M Kawakami; C W Angus; M D Lane; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

3.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.

Authors:  J Vieira; J Messing
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

4.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

5.  Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum.

Authors:  F C Kull; P Cuatrecasas
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

6.  Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors.

Authors:  H Engelmann; D Novick; D Wallach
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

7.  The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.

Authors:  B Mosley; M P Beckmann; C J March; R L Idzerda; S D Gimpel; T VandenBos; D Friend; A Alpert; D Anderson; J Jackson
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

8.  Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha).

Authors:  H P Hohmann; R Remy; M Brockhaus; A P van Loon
Journal:  J Biol Chem       Date:  1989-09-05       Impact factor: 5.157

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Soluble cytokine receptors are present in normal human urine.

Authors:  D Novick; H Engelmann; D Wallach; M Rubinstein
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  17 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

2.  Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-alpha antibody.

Authors:  J Jansen; T van der Poll; M Levi; H ten Cate; H Gallati; J W ten Cate; S J van Deventer
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

Review 3.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

4.  Increased release of the tumour necrosis factor receptor p75 by immortalized human keratinocytes results from an activated shedding mechanism and is not related to augmented steady-state levels of p75 mRNA.

Authors:  P Neuner; M Pourmojib; G Klosner; F Trautinger; R Knobler
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

Review 5.  Tumor necrosis factor receptors--structure and function.

Authors:  J Rothe; G Gehr; H Loetscher; W Lesslauer
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

6.  Chimeric tumor necrosis factor-TrkA receptors reveal that ligand-dependent activation of the TrkA tyrosine kinase is sufficient for differentiation and survival of PC12 cells.

Authors:  G Rovelli; R A Heller; M Canossa; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

7.  Structural and functional studies on the human hepatic interleukin-6 receptor. Molecular cloning and overexpression in HepG2 cells.

Authors:  H Schooltink; T Stoyan; D Lenz; H Schmitz; T Hirano; T Kishimoto; P C Heinrich; S Rose-John
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

Review 8.  Tumour necrosis factor and cancer.

Authors:  Frances Balkwill
Journal:  Nat Rev Cancer       Date:  2009-04-03       Impact factor: 60.716

9.  Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.

Authors:  L S Rusten; E B Smeland; F W Jacobsen; E Lien; W Lesslauer; H Loetscher; C M Dubois; S E Jacobsen
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis.

Authors:  W G Hoeck; C S Ramesha; D J Chang; N Fan; R A Heller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.